Savara, Inc. (SVRA)
4.45
-0.29
(-6.12%)
USD |
NASDAQ |
Oct 16, 16:00
4.52
+0.07
(+1.57%)
After-Hours: 20:00
Savara Net Income (TTM) : -139.31M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -139.31M |
| March 31, 2026 | -129.48M |
| December 31, 2025 | -118.84M |
| September 30, 2025 | -115.64M |
| June 30, 2025 | -110.33M |
| March 31, 2025 | -102.17M |
| December 31, 2024 | -95.88M |
| September 30, 2024 | -82.94M |
| June 30, 2024 | -75.29M |
| March 31, 2024 | -64.49M |
| December 31, 2023 | -54.70M |
| September 30, 2023 | -48.90M |
| June 30, 2023 | -42.69M |
| March 31, 2023 | -40.41M |
| December 31, 2022 | -38.15M |
| September 30, 2022 | -39.16M |
| June 30, 2022 | -39.32M |
| March 31, 2022 | -41.10M |
| December 31, 2021 | -43.01M |
| September 30, 2021 | -45.44M |
| June 30, 2021 | -45.96M |
| March 31, 2021 | -44.41M |
| December 31, 2020 | -49.61M |
| September 30, 2020 | -67.59M |
| June 30, 2020 | -68.93M |
| Date | Value |
|---|---|
| March 31, 2020 | -81.48M |
| December 31, 2019 | -78.17M |
| September 30, 2019 | -56.97M |
| June 30, 2019 | -57.12M |
| March 31, 2019 | -46.78M |
| December 31, 2018 | -61.52M |
| September 30, 2018 | -57.50M |
| June 30, 2018 | -51.76M |
| March 31, 2018 | -51.67M |
| December 31, 2017 | -29.80M |
| September 30, 2017 | -27.26M |
| June 30, 2017 | -23.67M |
| March 31, 2017 | -14.22M |
| December 31, 2016 | -20.45M |
| September 30, 2016 | -26.65M |
| June 30, 2016 | -33.33M |
| March 31, 2016 | -41.43M |
| December 31, 2015 | -39.84M |
| September 30, 2015 | -36.99M |
| June 30, 2015 | -34.95M |
| March 31, 2015 | -31.95M |
| December 31, 2014 | -28.70M |
| September 30, 2014 | -27.09M |
| June 30, 2014 | -24.48M |
| March 31, 2014 | -22.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Gilead Sciences, Inc. | -3.24B |
| Insmed, Inc. | -875.31M |
| United Therapeutics Corp. | 1.311B |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| ACADIA Pharmaceuticals, Inc. | 380.48M |